Second Edition of Ketamine-Assisted Therapy Training in Barcelona
BARCELONA, Spain , July 15, 2025 /PRNewswire/ -- Barcelona hosts pioneering training in ketamine-assisted psychotherapy The Ketamine Research Foundation (USA) and...
Neuroscience
10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025
PLEASANTON, Calif., July 10, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology,...
Study Finds Link Between Brain Injury and Criminal Behavior
Study shows criminality is associated with damage to a key brain pathway involved in emotional control and judgment AURORA, Colo.,...
LG Debuts Next-Generation Precision Medical AI
Joint Development Underway: World-Class Precision Medical AI Platform with Vanderbilt University Medical Center SEOUL, South Korea, July 10, 2025 /PRNewswire/ --...
Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
ISB 2001 is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) NEW YORK and NORTH...
Angelini Ventures Co-leads CHF 79 Million (€84 Million) Series B Financing of NUCLIDIUM to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform
- Regina Hodits, Managing Director to join NUCLIDIUM’s Board of Directors Rome, Italy, 10th July 2025 – Angelini Ventures, the corporate...
Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China
SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”),...
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861
NMRA-861 has potential best-in-class pharmacology, which may enable a more favorable therapeutic profile No convulsions observed in pre-clinical studies conducted...
Metabolon Announces a Quarter Century of Scientific Innovation, Industry Leadership, and Transformative Contributions to Life Science
A recognized pioneer in metabolomics, Metabolon is the most experienced and trusted metabolomics partner in the life sciences industry MORRISVILLE,...
Wearable EEG Devices Market Size to Grow by USD 695.51 million by 2031, Experiences Growth Owing to Growing Prevalence of Neurological Disorders | The Insight Partners
NEW YORK, July 4, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global wearable...
Strüngmann Award Honors Araris Biotech Founding Team as 2025 Winner
The expert jury selected Dragan Grabulovski, Ph.D., Philipp Spycher, Ph.D., and Isabella Attinger-Toller, Ph.D. of Araris Biotech, from a group...
Adhere+ Announces Acceptance of Two Scientific Posters at the 2025 American Society of Pain & Neuroscience (ASPN) Annual Conference
Posters highlight Remote Therapeutic Monitoring (RTM) implementation insights and outcomes from more than 2.2 million patient-reported observations WASHINGTON, July 1,...
Former Moderna Chief Development Officer Melanie Ivarsson OBE Joins PhaseV’s Scientific Advisory Board
Veteran Global Clinical Leader, Honored for Helping Develop One of the First COVID Vaccines, to Support Rollout of PhaseV's New...
Outlook Therapeutics Appoints Biopharmaceutical Industry and Commercial Leader Bob Jahr as Chief Executive Officer
Well-established executive with over 20 years of experience building and leading commercial teams across diverse therapeutic markets and geographies Career...
Axxess Partners With Zing Performance to Expand Access to Brain Health Solutions Through Home-Based Care
DALLAS, June 30, 2025 /PRNewswire/ -- Axxess, the leading global technology platform for healthcare at home, has partnered with Zing...
EVA Pharma and Zhejiang Jinhua CONBA Bio-Pharm Sign Strategic Supply Agreement
Two Regional Powerhouses to Strengthen Cross-Border Collaboration for a More Resilient and Accessible Healthcare Supply ChainSHANGHAI and CAIRO, June 30,...
MGI ANNOUNCES PARTNERSHIP WITH NEGEDIA: ENHANCE GENOMIC SEQUENCING TECHNOLOGIES AT THE SERVICE OF SCIENTIFIC RESEARCH AND PRECISION MEDICINE IN ITALY
In the study of rare diseases and precision medicine, understanding gene expression in the spatial context of tissues is essential. High-throughput...
Rewriting the Timeline of Detection: Linus Health’s Digital Platform Uncovers the Earliest Signs of Cognitive Decline
New research reveals that subtle response-time biomarkers—captured in minutes via digital assessments—can flag Alzheimer's and dementia risk far earlier than...
Corundum Convergence Institute and the University of Tokyo’s International Research Center for Neurointelligence Launch Inaugural Neuroscience Entrepreneurship Workshop
Neuro-inspired Computation and Entrepreneurship Workshop Will Equip the Next Generation of Neuroscience Entrepreneurs with Foundational Tools for Startup Creation TOKYO,...
ORYZON to Host Virtual KOL Event on July 9, 2025
To discuss the unmet medical need in Borderline Personality Disorder (BPD) and the design of vafidemstat’s Phase III PORTICO-2 trial...